Clinical Trial Update: Residual Neuromuscular Blockade in Cardiac Surgery Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating residual neuromuscular blockade in cardiac surgery patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Residual Neuromuscular Blockade

Snippet

Sponsor: Henry Ford Health System | Conditions: Residual Neuromuscular Blockade | Phase 4 | Status: WITHDRAWN